Polyamines as an inhibitor on erythropoiesis of hemodialysis patients by in vitro bioassay using the fetal mouse liver assay.
The pathogenesis of anemia in patients with chronic renal failure has been greatly attributed to erythropoietin (EPO) deficiency. Recently, however, there has been some thought that uremic inhibitors might suppress the activity of EPO and reduce the maturation of erythropoiesis. Polyamines are well known to be involved in the regulation of cellular proliferation and differentiation. Furthermore, the polyamine levels in the serum or erythrocytes are elevated in chronic hemodialysis patients, and can be lowered immediately by hemodialysis. In the present study, we first measured the polyamines levels (putrescine, spermidine, spermine) by high performance liquid chromatography (HPLC) in 20 chronic hemodialysis patients, and investigated the effects of polyamines on erythropoiesis by in vitro bioassay using fetal mouse liver cells. The direct effects of polyamines in erythroid colony formation in the medium with and without EPO were evaluated. Each polyamine level in chronic hemodialysis patients was higher than in the healthy subjects, and a significant negative correlation was found between polyamines and erythropoiesis. Polyamines inhibited the activity of EPO, but they did not have any direct effect on colony formation of the fetal mouse liver cells. These results suggest that polyamines have inhibitory effects on the proliferation or maturation of erythroid precursor cells and are intimately involved in the pathogenesis of renal anemia in chronic hemodialysis patients.
Yoshida
Katsunori
K
Division of Dialysis Unit, Nara Medical University Hospital, Nara-ken, Japan. Kappo@naramed-u.ac.jp
Yoneda
Tatsuo
T
Kimura
Syouki
S
Fujimoto
Kiyohide
K
Okajima
Eigoro
E
Hirao
Yoshihiko
Y
D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000503:physiopathology*; D000818:Animals; D001681:Biological Assay / Q000379:methods; D049109:Cell Proliferation; D002478:Cells, Cultured / Q000378:metabolism; D002648:Child; D015672:Erythroid Precursor Cells / Q000187:drug effects*; D004920:Erythropoiesis / Q000187:drug effects / Q000502:physiology*; D004921:Erythropoietin / Q000037:antagonists & inhibitors*; D005260:Female; D022781:Hepatocytes / Q000378:metabolism*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000378:metabolism; D008297:Male; D051379:Mice; D008875:Middle Aged; D011073:Polyamines / Q000097:blood / Q000494:pharmacology*; D006435:Renal Dialysis / Q000009:adverse effects
D011073:Polyamines; D004921:Erythropoietin